- Home
- OMIC vs GROW Comparison
OMIC vs GROW Comparison
Compare OMIC & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMIC
- GROW
- Stock Information
- Founded
- OMIC 2016
- GROW 1968
- Country
- OMIC United States
- GROW United States
- Employees
- OMIC 127
- GROW N/A
- Industry
- OMIC Medical/Dental Instruments
- GROW Investment Managers
- Sector
- OMIC Health Care
- GROW Finance
- Exchange
- OMIC Nasdaq
- GROW Nasdaq
- Market Cap
- OMIC 49.8M
- GROW 33.1M
- IPO Year
- OMIC 2021
- GROW N/A
- Fundamental
- Price
- OMIC $19.66
- GROW $2.46
- Analyst Decision
- OMIC Hold
- GROW
- Analyst Count
- OMIC 2
- GROW 0
- Target Price
- OMIC $10.75
- GROW N/A
- AVG Volume (30 Days)
- OMIC 24.5K
- GROW 23.6K
- Earning Date
- OMIC 11-12-2024
- GROW 02-06-2025
- Dividend Yield
- OMIC N/A
- GROW 3.66%
- EPS Growth
- OMIC N/A
- GROW N/A
- EPS
- OMIC N/A
- GROW 0.12
- Revenue
- OMIC $2,667,000.00
- GROW $10,008,000.00
- Revenue This Year
- OMIC $3.98
- GROW N/A
- Revenue Next Year
- OMIC $242.05
- GROW N/A
- P/E Ratio
- OMIC N/A
- GROW $20.31
- Revenue Growth
- OMIC 2.77
- GROW N/A
- 52 Week Low
- OMIC $5.34
- GROW $2.38
- 52 Week High
- OMIC $23.41
- GROW $2.95
- Technical
- Relative Strength Index (RSI)
- OMIC 47.98
- GROW 55.63
- Support Level
- OMIC $19.25
- GROW $2.41
- Resistance Level
- OMIC $20.00
- GROW $2.49
- Average True Range (ATR)
- OMIC 0.65
- GROW 0.04
- MACD
- OMIC -0.07
- GROW 0.00
- Stochastic Oscillator
- OMIC 22.76
- GROW 66.67
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.